Article Name Regulatory
Spanning Radiology, Cardiology, Neurology, and More, the List Highlights FDA’s Ongoing Commitment to Advancing Safe and Effective AI Integration in Healthcare
14th July, 2025
AI-Powered 3D Surgical Planning Tool Advances Precision Breast Cancer Surgery with Latest Regulatory Milestone
10th July, 2025
Innovative software platform leverages artificial intelligence to personalize therapy decisions and improve clinical outcomes for prostate cancer patients.
10th July, 2025
Study to Evaluate Accuracy and Clinical Impact of XR-Guided Soft Tissue Biopsy Across Leading U.S. Medical Centers
09th July, 2025
Milestone enhances clinical use of the FARAPULSE™ Pulsed Field Ablation platform for treatment of atrial fibrillation, strengthening its role in next-generation cardiac electrophysiology.
08th July, 2025
Regulatory milestone paves the way for expanded access to Morphic’s non-implant, incisionless solution for treating acid reflux and related gastrointestinal disorders across Europe.
08th July, 2025
Ceramic-based hip resurfacing implant gains European regulatory approval, offering patients a bone-preserving, metal-free alternative for hip joint restoration.
04th July, 2025
Comprehensive Report Highlights Emerging Trends, Market Drivers, and Forecasts Shaping the Future of the Medical Devices Industry.
04th July, 2025
Dual AI-Powered Imaging Software Set to Enhance Diagnostic Confidence and Workflow Efficiency in MRI
03rd July, 2025
Regulatory submission for Class IIb CE Mark and ISO 13485 certification paves the way for European launch of Median’s AI-driven SaMD platform targeting early lung cancer detection.
03rd July, 2025
CE Mark Approval Advances Precision Thrombectomy with Vessel-Conforming Design for Improved Stroke Outcomes Across Europe
02nd July, 2025
Regulatory Approval Enables AISight® Dx Use in Primary Diagnosis, Advancing AI-Powered Pathology Solutions
01st July, 2025
Tip separation during angiographic procedures may lead to life-threatening complications including embolism, sepsis, and cardiac arrhythmia; three serious injuries reported, prompting urgent recall.
26th June, 2025
Misapplied adhesive in Bravo CF capsule delivery systems linked to 33 serious injuries; Medtronic initiates urgent recall as FDA warns of high-risk complications including aspiration, perforation, and delayed diagnosis.
25th June, 2025
Following multiple unresolved warnings, the U.S. FDA enforces import restrictions on 42 Olympus endoscopic devices, spotlighting persistent quality system lapses at its Aizu facility in Japan and triggering global scrutiny of manufacturing and patient safety standards.
25th June, 2025
Next-Gen Stroke Device Aims to Enhance Clot Removal and Improve Outcomes in Ischemic Stroke Treatment Across Europe
19th June, 2025
88% of Companies Set Modernization Plans in Motion Within Three Years
09th June, 2025
Regulatory Milestone Validates JBA AI’s Clinical-Grade Software for Advanced Diagnostic Support
09th June, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer